AC
MRNA icon

AXQ Capital’s Moderna MRNA Stock Holding History

AXQ Capital’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.57M Buy
+22,477
New +$1.16M 0.17% 179
2026
Q1 		– Sell
-61,584
Closed -$1.82M – 1169
2025
Q4 		$1.82M Buy
61,584
+39,835
+183% +$1.08M 0.41% 38
2025
Q3 		$562K Buy
21,749
+11,650
+115% +$325K 0.22% 158
2025
Q2 		$279K Buy
+10,099
New +$266K 0.09% 383

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

AXQ Capital's MRNA Position: Q2 2026 in Review

AXQ Capital opened a new position in Moderna (MRNA) in Q2 2026: 22,477 shares worth $1.57M. The stake represents 0.17% of the portfolio and ranks #179 among its holdings. This is a return to the name: AXQ Capital previously reported a position in MRNA as recently as Q4 2025.

AXQ Capital first reported a position in MRNA in Q2 2025 and has held it in 4 quarters since. The position peaked at $1.82M in Q4 2025. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • AXQ Capital held 22,477 shares of Moderna worth $1.57M as of Q2 2026.
  • Moderna was a new AXQ Capital position in Q2 2026.
  • Moderna made up 0.17% of AXQ Capital's portfolio in Q2 2026, its #179 holding.
  • AXQ Capital first reported a position in Moderna in Q2 2025 and has held it in 4 quarters since.
  • AXQ Capital's Moderna position peaked at $1.82M in Q4 2025.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.